Akademska digitalna zbirka SLovenije - logo
E-viri
Celotno besedilo
Recenzirano
  • Discovery of Novel and High...
    Kling, Andreas; Jantos, Katja; Mack, Helmut; Hornberger, Wilfried; Drescher, Karla; Nimmrich, Volker; Relo, Ana; Wicke, Karsten; Hutchins, Charles W; Lao, Yanbin; Marsh, Kennan; Moeller, Achim

    Journal of medicinal chemistry, 08/2017, Letnik: 60, Številka: 16
    Journal Article

    Calpain overactivation has been implicated in a variety of pathological disorders including ischemia/reperfusion injury, cataract formation, and neurodegenerative diseases such as Alzheimer’s disease (AD). Herein we describe our efforts leading to the identification of ketoamide-based 2-(3-phenyl-1H-pyrazol-1-yl)­nicotinamides as potent and reversible inhibitors of calpain with high selectivity versus related cysteine protease cathepsins, other proteases, and receptors. Broad efficacy in a set of preclinical models relevant to AD suggests that inhibition of calpain represents an attractive approach with potential benefit for the treatment of AD.